-
srdr.ahrq.gov/projects/1520/studies/186693
January 01, 2019 - intervention (non-placebo)
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 28
Male
43
Comments ( 0 ) |
Post/View
Participant … IQR
48.3-63.2
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/186781
January 01, 2019 - IR: No percutaneous drainage
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 58.1
Male
59.3
Comments ( 0 ) |
Post/View
Participant … 13
SD
13
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/186139
January 01, 2010 - Ertapenem
Antibiotic: Ertapenem
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 55.4
Male
54.7
Comments ( 0 ) |
Post/View
Participant … 11.9
SD
12.1
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/186725
January 01, 2016 - Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 46.2
Male
44.5
Comments ( 0 ) |
Post/View
Participant … Participant Age - Categorical data
<50 years
<50 years … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/186762
January 01, 2014 - Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … race/ethnicity in parentheses
1.9
Comments ( 0 ) |
Post/View
Participant … 11.76
SD
11.04
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/197514
January 01, 2020 - Colonoscopy
Flexible sigmoidoscopy
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 35
Male
37
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1520/studies/193255
January 01, 2019 - Baseline Characteristics
Question
Colonoscopy
Total
Comments
Answer Follow-up
Answer Follow-up
Participant … characteristics
Male
51
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1520/studies/193256
January 01, 2019 - Baseline Characteristics
Question
Colonoscopy
Total
Comments
Answer Follow-up
Answer Follow-up
Participant … characteristics
Male
60.3
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1520/studies/192909
January 01, 2019 - Baseline Characteristics
Question
Colonoscopy
Total
Comments
Answer Follow-up
Answer Follow-up
Participant … characteristics
Male
28
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/189225
January 01, 2015 - CPAP
No CPAP
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 49-63
Comments ( 0 ) |
Post/View
Participant … concealment (Cochrane)
No
Comments ( 0 ) |
Post/View
Participant … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/188958
January 01, 2012 - CPAP
CPAP
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … No
Comments ( 0 ) |
Post/View
Participant … Comments ( 0 ) |
Post/View
Participant blinding (Cochrane)
No
Patients … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/189171
January 01, 2005 - Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 8.1
Comments ( 0 ) |
Post/View
Participant … Cochrane)
Not Applicable
Comments ( 0 ) |
Post/View
Participant … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/188968
January 01, 2012 - CPAP
No CPAP
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 7.5
Comments ( 0 ) |
Post/View
Participant … concealment (Cochrane)
Yes
Comments ( 0 ) |
Post/View
Participant … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/189005
January 01, 2011 - Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 11.6
Comments ( 0 ) |
Post/View
Participant … concealment (Cochrane)
Yes
Comments ( 0 ) |
Post/View
Participant … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/188323
January 01, 2016 - CPAP
No CPAP
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 8.2
Comments ( 0 ) |
Post/View
Participant … Allocation concealment (Cochrane)
Comments ( 0 ) |
Post/View
Participant … OSA Defn: OSA
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1520/studies/186403
January 01, 2012 - intervention (non-placebo)
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 36
Male
29
Comments ( 0 ) |
Post/View
Participant … 94
Range
27–92
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1520/studies/186803
January 01, 2017 - Pharm: 5-ASA (3.0 g/d)
Placebo
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 0.6
Asian
0.3
Comments ( 0 ) |
Post/View
Participant … 9.5
SD
9.3
Comments ( 0 ) |
Post/View
Participant … Was selection of participants into the study (or into the analysis) based on participant characteristics … Comments ( 0 ) |
Post/View
Q2: Did the study divide the follow up time of each individual participant
-
srdr.ahrq.gov/projects/1565/studies/189207
January 01, 2011 - Baseline Characteristics
Question
Total
Comments
Answer Follow-up
Participant … Participant Age - Categorical data
No data entered.
≥65 years (%)
No data entered.
-
srdr.ahrq.gov/projects/1520/studies/186821
January 01, 2019 - Baseline Characteristics
Question
Colonoscopy
Total
Comments
Answer Follow-up
Answer Follow-up
Participant … characteristics
Male
62
Comments ( 0 ) |
Post/View
Participant
-
srdr.ahrq.gov/projects/1565/studies/189001
January 01, 2016 - CPAP
No CPAP
Total
Comments
Answer Follow-up
Answer Follow-up
Answer Follow-up
Participant … 9.0
Comments ( 0 ) |
Post/View
Participant … Comments ( 0 ) |
Post/View
Participant blinding (Cochrane)
No … OSA Defn: OSA
Yes
Comments ( 0 ) |
Post/View
Participant